Avacta Group (LON:AVCT) Share Price Breaks Below Two Hundred Day Moving Average – Should You Sell?

Avacta Group Plc (LON:AVCT)’s share price passed below its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of GBX 71.81 and traded as low as GBX 63.22. Avacta Group shares last traded at GBX 66.31, with a volume of 3,231,600 shares trading hands.

Avacta Group Stock Performance

The company has a market capitalization of £299.31 million, a PE ratio of -7.09 and a beta of 1.12. The firm has a 50-day moving average of GBX 69.70 and a two-hundred day moving average of GBX 71.78. The company has a quick ratio of 4.96, a current ratio of 0.95 and a debt-to-equity ratio of 526.98.

Avacta Group (LON:AVCT) last issued its earnings results on Wednesday, September 30th. The biotechnology company reported GBX (4.23) EPS for the quarter. Avacta Group had a negative net margin of 35,730.97% and a negative return on equity of 1,293.07%. Research analysts anticipate that Avacta Group Plc will post -9.9011833 EPS for the current year.

About Avacta Group

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.

Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).